What's happening
This bill establishes a regulated framework in New York for adult use, cultivation, and support services related to psilocybin-containing fungi.
Why it matters
Expands access to psilocybin for adults with a wide range of health conditions. The bill allows adults to obtain a psilocybin permit if they self-report symptoms or diagnoses from an extensive list of physical and mental health conditions, including depression, PTSD, chronic pain, substance use disorders, and even emerging or novel health conditions supported by scientific evidence. This broad eligibility could make psilocybin accessible to many New Yorkers seeking alternative therapies.
Implements a structured, health-focused permitting and education process. To use psilocybin legally, adults must complete a health screening (either online or with a licensed provider) and a safety-focused educational course. The process emphasizes informed consent, risks, and contraindications, and requires periodic renewal and updates, aiming to maximize safety and minimize misuse.
Establishes new professional roles and commercial opportunities. The bill creates a certification for non-medical “support services providers” who can offer risk-reduction support during psilocybin use for a fee, without offering therapy or medical treatment. It also allows for licensed cultivators to engage in regulated commercial production and sale, with stringent safety, labeling, and testing requirements—potentially opening a new regulated industry in New York.
Removes criminal penalties and provides legal protections for participants. Once regulated, psilocybin and psilocin are removed from New York’s controlled substances schedules for those participating in the program, and permit holders, licensed cultivators, and support providers are protected from arrest, prosecution, or professional discipline for authorized activities. However, unlicensed sales or use remain penalized, and workplace impairment and federal law considerations are preserved.
Creates oversight and ongoing policy development via an advisory board. The bill establishes a diverse advisory board to guide implementation, update exclusion criteria, and develop best practices, with mandated program reviews and audits to ensure the system remains safe, effective, and equitable. This built-in oversight could help adapt the program as scientific understanding and social needs evolve.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Adults with qualifying health conditions
People eighteen and older with conditions such as PTSD, depression or chronic pain could obtain permits to buy, grow and use psilocybin after completing health screening and education, provided they meet no exclusion criteria.
Psilocybin cultivators and delivery businesses
Licensed cultivators could sell directly to permit holders, including through contracted delivery services, subject to testing, labeling, storage and inspection requirements.
Support services providers
State certification would allow providers to charge for nonmedical risk-reduction support, with training, continuing education and informed-consent requirements, but would not itself authorize therapy or treatment.
New York State Department of Health
The department would administer permits, cultivator licenses and provider certifications, establish regulations and reporting systems, and oversee the new psilocybin framework.
Headline styles
Legalize Medical Psilocybin Use
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
Full text
12 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
10375
IN ASSEMBLY
May 21, 2024
Introduced by COMMITTEE ON RULES -- (at request of M. of A. Paulin) -read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to promoting the health and well-being of the citizens of the state of New York by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Article 33 of the public health law is amended by adding a new title 5-B to read as follows:
TITLE V-B
REGULATED HEALTH ACCESS AND SUPPORT SERVICES FOR PSILOCYBIN ACT Section 3369-aa. Definitions.
3369-bb. Regulation of psilocybin programs.
3369-cc. Regulated adult use of psilocybin in connection with
public health framework.
3369-dd. Certification and authorized services of support
services provider.
3369-ee. Cultivator license and requirements.
3369-ff. Relation to other laws.
3369-gg. Protections.
3369-hh. Regulated psilocybin advisory board.
3369-ii. Taxation of psilocybin regulated activities.
§ 3369-aa. Definitions. For the purposes of this title, the following terms shall have the following meanings:
1. "Business enterprise" means any entity, including a sole proprietorship, partnership, limited liability partnership, limited liability company or corporation, including not-for-profit corporations, which is authorized to and engages in lawful business transactions in accordance with New York law.
2. "Adult use of psilocybin" means the authorized adult, non-commercial use of psilocybin in connection with a public health framework as provided under this title.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD15437-03-4
3. "Cultivator license" means a written authorization permitting natural persons or business enterprises to engage in the specified activities of cultivation, distribution, and testing of psilocybin, as authorized pursuant to this title. Only a person or business enterprise with a cultivator license may engage in commercial transactions with psilocybin-containing fungi.
4. "Department" shall mean New York state department of health.
5. "Exclusion criteria" means certain health conditions, prescription medications, or consumption of other substances that, based on currently available medical information and research, are contraindicated or have a risk of negative interaction with the use of psilocybin. Exclusion criteria shall be added or removed by the department.
6. "Health screening" means a screening form to allow a person to certify symptoms or prior or current diagnosis of one or more health conditions or exclusion criteria.
7. "Licensed healthcare provider" means a person with a valid license or certificate from the department of education for a profession provided in article one hundred thirty-one, one hundred thirty-two, one hundred thirty-six, one hundred thirty-nine, one hundred forty, one hundred forty-one, one hundred forty-three, one hundred fifty-three, one hundred fifty-four, one hundred fifty-seven, one hundred fifty-nine, one hundred sixty, one hundred sixty-three, one hundred sixty-four, or one hundred sixty-seven or otherwise related to wellness, medicine, healthcare, mental health, or behavioral health. To be a licensed healthcare provider under this title, such licensed professional's authorized scope of practice does not need to but may include medical diagnosis or prescription of medications.
8. "Health conditions" mean certain health conditions that include but are not limited to:
(a) adjustment disorder;
(b) amyotrophic lateral sclerosis;
(c) attention deficit/hyperactivity disorder;
(d) arthritis;
(e) autism;
(f) Alzheimer's;
(g) anxiety;
(h) anorexia nervosa;
(i) bacterial infection or disease;
(j) behavioral/process addiction, including gambling, pornography, or shopping;
(k) body dysmorphia;
(l) cataracts;
(m) cancer;
(n) cancer-related distress;
(o) chronic pain;
(p) chronic fatigue;
(q) cluster headaches;
(r) depressive disorder;
(s) degenerative disc or joint disease;
(t) eating disorder;
(u) effects from stroke;
(v) epilepsy;
(w) episodic migraines;
(x) fibromyalgia;
(y) functional gastrointestinal disorder, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD);
(z) glaucoma;
(aa) headache disorders;
(bb) HIV/AIDS;
(cc) insomnia;
(dd) Lyme disease;
(ee) mood disorder;
(ff) motor neuron disease;
(gg) migraine;
(hh) multiple sclerosis;
(ii) muscular dystrophy;
(jj) neurodegenerative disease including neuropathy;
(kk) obsessive-compulsive disorder;
(ll) Parkinson's disease;
(mm) panic disorder;
(nn) paresthesia;
(oo) phantom limb pain;
(pp) premenstrual syndrome or premenstrual dysphoric disorder;
(qq) prolonged grief disorder;
(rr) postpartum mental health disorder;
(ss) post-acute COVID-19 infection condition;
(tt) post-traumatic stress disorder (PTSD) or complex post-traumatic stress disorder;
(uu) psychogenic pain disorder;
(vv) restless leg syndrome;
(ww) rheumatoid arthritis;
(xx) sexual disorder;
(yy) sensory processing disorder;
(zz) sleep disorder;
(aaa) substance use disorder, including for use of opiates, tobacco, and alcohol;
(bbb) terminal illness or end-of-life distress;
(ccc) traumatic brain injury (TBI), including concussion;
(ddd) treatment resistant depression;
(eee) unspecified mood disorder; and
(fff) any novel or emergent health condition not categorized in the Diagnostic and Statistical Manual of Mental Disorders or known physical health conditions where there is evidence of potential use of psilocybin with positive outcomes in connection with such health conditions that has been identified in a study published in a medical or scientific journal, including preprint servers.
9. "Licensed cultivator" means a person or business enterprise, including a sole proprietorship, partnership, corporation, limited liability company, or other business enterprise, that possesses a cultivator license pursuant to this title.
10. "Noncommercial" means an action or transaction of goods that is without remuneration or the exchange of money.
11. "Permit course" means the psilocybin regulation educational permit (PREP) course that includes educational material and a test that must be successfully completed by a person who has received a health screening and is applying for a psilocybin permit. There will be no limit in the number of attempts to complete the test component of the permit course in order to receive a psilocybin permit, as the purpose of such test is to enable education and information to increase safety of adult use of psilocybin.
12. "Person" means a natural person.
13. "Psilocybin" means fungi that contain naturally-occurring psilocybin and psilocin compounds produced by such fungi, including but not limited to members of the genus Psilocybin.
14. "Psilocybin permit" means a written authorization from the department issued to a person at least eighteen years old who has received a health screening and successfully completed the permit course to allow adult use of psilocybin in connection with a public health framework.
15. "School grounds" means any building, structure, and surrounding outdoor grounds, including entrances or exits, contained within a public or private pre-school, nursery school, elementary or secondary school's legally defined property boundaries as registered in a county clerk's office.
16. "Support services" mean the services consistent with this title through actions of supportive care and response to adverse health circumstances, provision of educational information, and other conduct provided by a certified support services provider that increase the safety and reduce potential risks associated with a psilocybin permit holder's authorized use of psilocybin.
17. "Support services provider certification" means a certification that is regulated and issued by the department that authorizes the support services of a support services provider.
18. "Support services provider" means a person who has been granted a certification to provide risk reduction support services, upon completion and continued satisfaction of all requirements under section thirty-three hundred sixty-nine-cc of this title, including ongoing education and training in connection with a permit holder's adult use of psilocybin.
§ 3369-bb. Regulation of psilocybin programs. 1. The department shall manage all operations of this title.
2. The department shall promulgate regulations to implement this title.
3. The department may provide for the analysis and evaluation of the operation of this title. The department may enter into agreements with one or more persons, not-for-profit corporations, universities, or other organizations, for the performance of an evaluation of the implementation and effectiveness of this title.
4. The department shall be responsible for regulating the adult use of psilocybin with a permit, cultivation licenses and licensed cultivator operation requirements, certification of support services providers, and other authorized and related programs.
5. The department shall create a reporting program to allow permit holders the optional opportunity to identify health and experience data in connection with adult use of psilocybin, including on health conditions and potential exclusion criteria, and also to make reports about certified support services providers and the provision of ethical services.
6. The department shall report every two years, beginning two years after the effective date of this title, to the governor and the legislature on the regulated access of psilocybin under this title and make appropriate recommendations.
§ 3369-cc. Regulated adult use of psilocybin in connection with public health framework. A psilocybin permit holder shall be permitted to engage in the adult use of psilocybin in connection with qualifying health conditions, provided that:
1. A person shall be provided a psilocybin permit upon completion of a health screening and the permit course.
2. A person shall complete a health screening that certifies symptoms or diagnosis of any health conditions and no existence of exclusion criteria.
3. A health screening shall include a structured screening process with a form where a person applying for a psilocybin permit self-reports symptoms or diagnosis that indicate any health condition or exclusion criteria.
4. A health screening form shall be updated by the permit holder if there are any changes to the certifications of health conditions, including any new symptoms or diagnosis, that constitute exclusion criteria on the form filed with the department and recompleted biennially to maintain the psilocybin permit. Any changes to such form shall not precipitate a requirement to engage in the permit course until the four year requirement provided in this section.
5. A health screening shall include clear disclosure that adult use of psilocybin under this title is not to treat any health conditions and the existence of health assessments and treatments for any potential health conditions.
6. A health screening shall include clear disclosure that exclusion criteria in connection with use of psilocybin may increase significant health and safety risks.
7. Any indication of exclusion criteria shall disqualify a person from a psilocybin permit due to health risks to such person or others.
8. A health screening shall be allowed to be taken in an entirely online format provided by the department or with a licensed healthcare provider, who shall then submit such screening to the department.
9. The permit course, which shall be no longer than five (5) hours and allowed to be taken in an in-person or entirely online format, shall provide the appropriate education and information about psilocybin and psilocybin-containing fungi using a curriculum developed by the department regarding the history of indigenous, religious, and cultural use, safety, potency and effects of dosing amounts, contraindicated health conditions and substances, the value of preparation and integration, the appropriate setting for use, and any medically available evidence of benefits, health risks, and the sensitivity period subsequent to psilocybin use, and optional support services available, appropriate conduct and informed consent required for such services, and the department reporting system established pursuant to this title. The department shall update the curriculum for the permit course with medically available information biennially.
10. A permit holder must successfully complete an abbreviated renewal permit course based on changes to the curriculum or this title every four years to maintain such permit holder's permit.
11. The cost of the permit course and the permit application shall not exceed reasonable, accessible fees consistent with other state permits. A permit course shall not exceed one hundred dollars and the permit application shall not exceed eighty dollars.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.